Velcade uses "iPatient" to spur sales

Velcade uses "iPatient" to spur sales
Velcade uses "iPatient" to spur sales

Velcade has been the market leader for the blood cancer myeloma since its 2003 introduction. Ten years and two competitive entrants later, Velcade is no longer alone at the top and has rolled out an “iPatient” sales aid.

“We saw two competitors, Kyprolis and Pomalyst, roll out in the past year,” says Philip Prince, senior product manager, Velcade marketing at Millennium Takeda. “We really wanted to invigorate the brand.”

The app continues last year's professional print campaign, with the tagline “Survival never gets old.” The iPatient sales aid offers four patient case studies as discussion points as well as other information to clarify who should be prescribed Velcade.

It's Takeda Millennium's second iPad app, but it's their first that “takes physicians through the patient journey with provocative case studies,” Prince said.

While the drug boasts strong efficacy, Velcade, as an IV treatment, also has debilitating side effects like peripheral neuropathy. Velcade was approved by FDA for subcutaneous administration in January 2012.

“With the launch of the subcutaneous route, we found through market research that physicians were developing a stronger emotional connection with Velcade based on a new ‘softer' perception—thanks to the different side-effect profile,” says Prince. “This change in perception allowed us to introduce a patient-focused campaign.”

So far, the move appears to have paid off: “With the launch of the iPatient App to our sales force at a recent congress, we more than doubled our targeted discussion length with physicians,” said Prince.

Millennium worked with Toronto-based digital agency Klick Health on the project. Klick also helped them develop an unbranded website earlier this year at
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.